Back to Search
Start Over
Germany : Merck Announces New Data Strengthening Evidence for Continued Safe and Effective MAVENCLAD Use During the COVID-19 Pandemic
- Source :
- Mena Report. April 26, 2021
- Publication Year :
- 2021
-
Abstract
- Merck, a leading science and technology company, today announced a new analysis from the MAGNIFY-MS sub-study showing a specific immune repopulation pattern in patients with relapsing multiple sclerosis (RMS) treated [...]
Details
- Language :
- English
- ISSN :
- 22190112
- Database :
- Gale General OneFile
- Journal :
- Mena Report
- Publication Type :
- News
- Accession number :
- edsgcl.659728179